United States · Platforms & data · Investing.com

J&J presents patient data on nipocalimab for Sjögren’s disease

Published by Investing.com · United States 2 h ago

J&J presents patient data on nipocalimab for Sjögren’s disease — Investing.com

Read the full article on Investing.com Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investing.com)

Also worth reading

Kardigan Extends Phase 2 Ataciguat Trial Assessment, Targets 2027 Results

The Motley Fool

Prediction: These Are the 3 Biggest Threats Facing SpaceX in 2027

Insider trades: Netflix, Intel, Visa among notable names

Why the prognosis for healthcare stocks is uncertain ahead of Congress’ new makeup

My 93-year-old father changed his will at the 11th hour, leaving my brother his entire $500,000 estate. Can I challenge it?

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030